Who owns BIOXCEL THERAPEUTICS INC COM NEW?
- Ticker: BTAI
- CUSIP Number: 09075p204
Tip: Access positions for across all investors
Analyze quarterly positions in Bioxcel Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Bioxcel Therapeutics stock
Who bought or sold BIOXCEL THERAPEUTICS INC COM NEW this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Millennium Management | 2.1M | $3.0M | 9% | Jun 2026 |
|
| Oaktree Capital Management | 1.4M | $1.9M | 472% | Jun 2026 |
|
| Vanguard Capital Management | 920k | $1.3M | 343% | Jun 2026 |
|
| Oaktree Fund Advisors | 246k | $346k | 472% | Jun 2026 |
|
| Geode Capital Management | 242k | $342k | 5% | Jun 2026 |
|
| BlackRock | 179k | $253k | 113% | Jun 2026 |
|
| UBS Group | 158k | $223k | 199% | Jun 2026 |
|
| Citadel Advisors | 149k | $210k | 100% | Jun 2026 |
|
| Vanguard Fiduciary Trust | 137k | $193k | 61% | Jun 2026 |
|
| State Street Corporation | 92k | $123k | 46% | Mar 2026 |
|
| FMR | 90k | $127k | 0% | Jun 2026 |
|
| Wiley Bros.-aintree Capital | 84k | $118k | 3% | Jun 2026 |
|
| Jones Financial Companies, L.L | 63k | $83k | -52% | Jun 2026 |
|
| Northern Trust | 56k | $79k | 55% | Jun 2026 |
|
| HighTower Advisors | 41k | $58k | 0% | Jun 2026 |
|
| Quadrature Capital | 38k | $54k | 100% | Jun 2026 |
|
| Headlands Technologies | 26k | $36k | 100% | Jun 2026 |
|
| Intl Fcstone | 21k | $29k | 100% | Jun 2026 |
|
| Beacon Pointe Advisors | 19k | $27k | 0% | Jun 2026 |
|
| Susquehanna International | 17k | $24k | 100% | Jun 2026 |
|
| Portfolio Strategies | 17k | $24k | 38% | Jun 2026 |
|
| Advisor Group Holdings | 16k | $23k | 0% | Jun 2026 |
|
| Virtu Financial | 16k | $23k | 100% | Jun 2026 |
|
| Diversify Wealth Management | 15k | $13k | 0% | Jun 2026 |
|
| Diversify Advisory Services | 15k | $13k | 100% | Jun 2026 |
|
| Two Sigma Securities | 11k | $15k | 100% | Jun 2026 |
|
| Morgan Stanley | 11k | $14k | 623% | Mar 2026 |
|
| Wells Fargo & Company | 4.3k | $6.0k | 0% | Jun 2026 |
|
| Barclays | 1.4k | $2.0k | 100% | Jun 2026 |
|
| Goss Wealth Management | 1.3k | $1.9k | 0% | Jun 2026 |
|
| Vanguard Global Advisers | 493.00 | $694.982100 | 0% | Jun 2026 |
|
| Silver Grove Financial Group | 331.00 | $468.000900 | -1% | Jun 2026 |
|
| Tower Research Capital | 227.00 | $320.001900 | -87% | Jun 2026 |
|
| Parkside Financial Bank & Trust | 112.00 | $157.998400 | 0% | Jun 2026 |
|
| Washington Trust Advisors | 82.00 | $115.997200 | -49% | Jun 2026 |
|
| EverSource Wealth Advisors | 60.00 | $85.002000 | 0% | Jun 2026 |
|
| Jpmorgan Chase & Co | 45.00 | $63.000000 | 100% | Jun 2026 |
|
| Mercer Global Advisors | 32.00 | $44.998400 | 100% | Jun 2026 |
|
| Farther Finance Advisors | 25.00 | $35.000000 | 0% | Jun 2026 |
|
| Northwestern Mutual Wealth Management Company | 21.00 | $30.000600 | 0% | Jun 2026 |
|
| IFP Advisors | 13.00 | $17.999800 | 0% | Jun 2026 |
|
| SBI Securities | 13.00 | $17.999800 | -7% | Jun 2026 |
|
| Bnp Paribas Arbitrage, Snc | 12.00 | $17.000400 | -80% | Jun 2026 |
|
| Zurcher Kantonalbank | 2.00 | $3.000000 | 0% | Jun 2026 |
|
| Us Bancorp | 1.00 | $1.000000 | 0% | Jun 2026 |
|
| Group One Trading | 1.00 | $1.000000 | 0% | Jun 2026 |
|
| Triumph Capital Management | 1.00 | $1.000000 | 0% | Mar 2026 |
|
Who sold out of Bioxcel Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Armistice Capital | Mar 2026 | 1.9M | $2.6M |
| Man Group | Mar 2026 | 97k | $129k |
| Annis Gardner Whiting Capital Advisors | Mar 2026 | 156.00 | $210.007200 |